Laevolac (Lactulose, Liquid)

Lactulose is a synthetic disaccharide that passes unchanged through the small intestine. In the colon, bacterial enzymes split it into short‑chain fatty acids, which increase osmotic pressure, draw water into the lumen, and lower pH. The acidic environment converts ammonia to ammonium, limiting its absorption and helping to soften stools.

The dose of Laevolac is individualized by the prescribing clinician based on the patient’s age, weight, severity of constipation or hepatic encephalopathy, and response to therapy. The healthcare provider determines the volume and frequency of the liquid preparation, and patients should follow the prescribed regimen exactly.

Safety data for lactulose in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Laevolac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, lactulose provides a gentler, osmotic mechanism that softens stool without causing abrupt intestinal contractions. It also offers the added benefit of reducing ammonia absorption, a feature not shared by most bulk‑forming agents. However, its onset of action may be slower, and it may be less effective for severe constipation requiring rapid evacuation.

Laevolac should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the bottle tightly closed, protect it from direct sunlight and moisture, and store it in its original packaging. Do not freeze the solution, and discard any product that appears discolored or has an off‑odor.

Laevolac is taken orally as a liquid. The prescribed volume is measured with a calibrated dosing device or syringe and consumed directly or mixed with a small amount of water or juice if needed for palatability. Doses are usually spaced several hours apart, and patients should maintain adequate fluid intake to support the osmotic effect.

The most serious risks include severe electrolyte disturbances such as hyponatremia or hypokalemia, dehydration from excessive diarrhea, and rare allergic reactions that may present as rash, swelling, or breathing difficulty. Patients experiencing persistent watery stools, dizziness, or signs of an allergic response should seek medical attention promptly.

Laevolac is contraindicated in individuals with known hypersensitivity to lactulose, those with intestinal obstruction, perforation, or severe inflammatory bowel disease. Caution is also advised for patients with uncontrolled diabetes, renal impairment, or severe liver failure, and it should be avoided in these populations unless a physician determines that the benefits outweigh the risks.